Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             34 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Acute phase treatment in central retinal artery occlusion: thrombolysis, hyperbaric oxygen therapy or both? Ferreira, Daniel

50 4 p. 984-988
artikel
2 Albumin and bleed risk in rivaroxaban treated patients Wojakowski, E.

50 4 p. 1004-1011
artikel
3 Argatroban therapy for heparin-induced thrombocytopenia in a patient with coronavirus disease 2019 Ogawa, Yoshihiko

50 4 p. 1012-1014
artikel
4 Assessment of the attitude, awareness and practice of periprocedural warfarin management among health care professional in Qatar. A cross sectional survey Eljilany, Islam

50 4 p. 957-968
artikel
5 A stricter control of low-density lipoprotein is necessary for thrombosis reduction in “lower thrombosis risk” patients with atrial fibrillation: a multicenter retrospective cohort study Liu, Weizhuo

50 4 p. 849-857
artikel
6 Bleeding prevalence in COVID-19 patients receiving intensive antithrombotic prophylaxis Kessler, Chiara

50 4 p. 833-836
artikel
7 Clinical significance of healed plaque detected by optical coherence tomography: a 2-year follow-up study Kurihara, Osamu

50 4 p. 895-902
artikel
8 Concerns for management of STEMI patients in the COVID-19 era: a paradox phenomenon Vlachakis, Panayotis K.

50 4 p. 809-813
artikel
9 Differentiating biochemical from clinical heparin resistance in COVID-19 Lisman, Ton

50 4 p. 1015-1016
artikel
10 Drug-induced disseminated intravascular coagulation: a pharmacovigilance study on World Health Organization’s database Bonaldo, Giulia

50 4 p. 763-771
artikel
11 Effect of erroneous body-weight estimation on outcome of thrombolyzed stroke patients Paliwal, Prakash R.

50 4 p. 921-928
artikel
12 Efficacy and safety of low dose rivaroxaban in patients with coronary heart disease: a systematic review and meta-analysis Khan, Safi U.

50 4 p. 913-920
artikel
13 Experience of a 40-day (6 week) LMWH treatment for isolated distal deep vein thrombosis Asonitis, Konstantinos

50 4 p. 837-843
artikel
14 How haemophilia A impacts severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) treatment: a case report Zanon, Ezio

50 4 p. 795-798
artikel
15 Implementation of automatic data extraction from an enterprise database warehouse (EDW) for validating pediatric VTE decision rule: a prospective observational study in a critical care population Schultz, Rachael F.

50 4 p. 782-789
artikel
16 Inflammatory markers in thrombosis associated with primary antiphospholipid syndrome Arantes, Fernanda T.

50 4 p. 772-781
artikel
17 In vivo demonstration of microvascular thrombosis in severe COVID-19 do Espírito Santo, Douglas Alexandre

50 4 p. 790-794
artikel
18 Long lasting hypercoagulability after subclinical COVID-19 Ferroli, Paolo

50 4 p. 822-824
artikel
19 Loop-mediated isothermal amplification (LAMP)-based method for detecting factor V Leiden and factor II G20210A common variants Luca Tiscia, Giovanni

50 4 p. 908-912
artikel
20 Low prevalence of JAK2 V617F mutation in patients with thrombosis and normal blood counts: a retrospective impact study Levraut, Michaël

50 4 p. 995-1003
artikel
21 Predictors for layered coronary plaques: an optical coherence tomography study Araki, Makoto

50 4 p. 886-894
artikel
22 Prominent coagulation disorder is closely related to inflammatory response and could be as a prognostic indicator for ICU patients with COVID-19 Liu, Yang

50 4 p. 825-832
artikel
23 Residual platelet reactivity, thrombus burden and myocardial reperfusion in patients treated by PCI after successful pre-hospital fibrinolysis compared to primary PCI Roule, Vincent

50 4 p. 858-866
artikel
24 Risk Of Thrombosis In Elderly Immune Primary Trombocytopenic Patients Treated with Thrombopoietin Receptors Agonists Castelli, Roberto

50 4 p. 903-907
artikel
25 Rivaroxaban-induced hemorrhagic pericardial tamponade in end-stage renal disease Rapista, Nicole

50 4 p. 982-983
artikel
26 Safety and efficacy of short-term (1 to 3 months) dual antiplatelet therapy in patients undergoing percutaneous coronary interventions: a meta-analysis of randomized controlled trials Kheiri, Babikir

50 4 p. 867-873
artikel
27 Severe high-molecular-weight kininogen deficiency due to a homozygous c.1456C > T nonsense variant in a large Chinese family Yang, Jing

50 4 p. 989-994
artikel
28 The Impact of platelet–fibrin clot strength on occurrence and clinical outcomes of peripheral artery disease in patients with significant coronary artery disease Bae, Jae Seok

50 4 p. 969-981
artikel
29 The role of P2Y12 receptor inhibition in ischemic stroke on microglia, platelets and vascular smooth muscle cells Li, Fengyang

50 4 p. 874-885
artikel
30 Thrombolysis in massive and submassive pulmonary embolism during pregnancy and the puerperium: a systematic review Rodriguez, David

50 4 p. 929-941
artikel
31 Thromboprophylaxis: balancing evidence and experience during the COVID-19 pandemic Marchandot, Benjamin

50 4 p. 799-808
artikel
32 Ticagrelor for the primary prevention of stroke in patients with coronary artery disease: a systematic review and meta-analysis of randomized controlled trials Kong, Qi

50 4 p. 942-956
artikel
33 Use of apixaban and rivaroxaban in young adults with acute venous thromboembolism: a multi-center retrospective case series DeCamillo, Deborah

50 4 p. 844-848
artikel
34 Venous thromboembolism in critically ill COVID-19 patients receiving prophylactic or therapeutic anticoagulation: a systematic review and meta-analysis Hasan, Syed Shahzad

50 4 p. 814-821
artikel
                             34 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland